Increased hepcidin expression in multibacillary leprosy by Brito de Souza, Vania Nieto et al.
  Universidade de São Paulo
 
2012
 
Increased hepcidin expression in multibacillary
leprosy
 
 
MEMORIAS DO INSTITUTO OSWALDO CRUZ, RIO DE JANEIRO, RJ, v. 107, n. 8, Special Issue,
supl. 1, Part 2, pp. 183-189, DEC, 2012
http://www.producao.usp.br/handle/BDPI/37745
 
Downloaded from: Biblioteca Digital da Produção Intelectual - BDPI, Universidade de São Paulo
Biblioteca Digital da Produção Intelectual - BDPI
Sem comunidade WoS
183
online | memorias.ioc.fiocruz.br
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 107(Suppl. I): 183-189, 2012
Iron is essential for the survival of all organisms; 
therefore, competition for this element is an important 
aspect of the host-pathogen interaction. The clinical ef-
fect of iron imbalance on infectious diseases has long 
been recognised: this issue was first discussed by Trous-
seau, in 1872, who observed that iron ingestion was as-
sociated with a poor prognosis in tuberculosis patients.
Elucidating the interaction between iron homeostasis 
and the immune response is crucial to improve our un-
derstanding of host-pathogen interactions in infectious 
diseases. Iron-binding compounds such as chelators or 
transporters are important targets of investigation. Hep-
cidin, an antimicrobial peptide produced by hepatocytes 
in response to excess iron or inflammation, is one of the 
principal iron regulatory hormones (Park et al. 2001). This 
iron transporter causes iron to accumulate inside cells by 
inducing the internalisation and destruction of ferropor-
tin, the sole known cellular iron exporter (Delaby et al. 
2005, Theurl et al. 2008). Anaemia and hypoxia decrease 
the production of hepcidin (Nicolas et al. 2002). 
Hepcidin has been considered a link between in-
flammation and anaemia of chronic diseases or anaemia 
of inflammation (AI), which is characterised by reduced 
levels of iron in the serum and increased iron reserves, 
as evidenced by elevated ferritin. Pro-inflammatory 
cytokines such as interleukin (IL)-6 and IL-1 connect 
the inflammatory response and AI by inducing hepcidin 
production (Nemeth et al. 2004, Lee et al. 2005). Bac-
terial infection of macrophages can also drive hepcidin 
production via Tool-like receptor (TLR)4 activation 
(Peyssonnaux et al. 2006). 
AI seems to be an adaptive anti-infection mechanism 
that acts by sequestering iron within cells. However, dur-
ing an infection with an intracellular pathogen, sequester-
ing iron in macrophages can actually be detrimental to the 
host. In fact, the expression of ferroportin limits the growth 
of intracellular bacteria in macrophage cultures, whereas 
hepcidin expression has the opposite effect (Paradkar et 
al. 2008). In contrast, hepcidin inhibits microbe growth in 
interferon (IFN)-γ-activated macrophages infected with 
mycobacteria and causes direct membrane damage in My-
cobacterium tuberculosis (Sow et al. 2007). 
The effects of iron on microbial survival are critical 
during therapies that modulate iron availability, as iron 
supplementation is associated with an increased risk of 
infection (reviewed by Johnson & Wessling-Resnick 
2012). Furthermore, iron chelators have been proposed 
as a possible therapy for chronic infections with intracel-
lular microorganisms (Murray et al. 1978, Sazawal et al. 
2006, Boelaert et al. 2007, Paradkar et al. 2008). 
Leprosy is an ancient disease caused by Mycobacte-
rium leprae, an intracellular mycobacterium that infects 
the skin and peripheral nerves, causing serious disabili-
ties. Despite the efficacy of available therapies, at the 
beginning of 2010, there were 211,903 registered cases 
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Iron is essential for all organisms and its availability can control the growth of microorganisms; therefore, we 
examined the role of iron metabolism in multibacillary (MB) leprosy, focusing on the involvement of hepcidin. Eryth-
rograms, iron metabolism parameters, pro-inflammatory cytokines and urinary hepcidin levels were evaluated in 
patients with MB and matched control subjects. Hepcidin expression in MB lesions was evaluated by quantitative 
polymerase chain reaction. The expression of ferroportin and hepcidin was evaluated by immunofluorescence in 
paucibacillary and MB lesions. Analysis of hepcidin protein levels in urine and of hepcidin mRNA and protein levels 
in leprosy lesions and skin biopsies from healthy control subjects showed elevated hepcidin levels in MB patients. 
Decreases in haematologic parameters and total iron binding capacity were observed in patients with MB leprosy. 
Moreover, interleukin-1 beta, ferritin, soluble transferrin receptor and soluble transferrin receptor/log ferritin index 
values were increased in leprosy patients. Hepcidin was elevated in lepromatous lesions, whereas ferroportin was 
more abundant in tuberculoid lesions. In addition, hepcidin and ferroportin were not colocalised in the biopsies 
from leprosy lesions. Anaemia was not commonly observed in patients with MB; however, the observed changes in 
haematologic parameters indicating altered iron metabolism appeared to result from a mixture of anaemia of in-
flammation and iron deficiency. Thus, iron sequestration inside host cells might play a role in leprosy by providing 
an optimal environment for the bacillus.
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worldwide (WHO 2010). Leprosy cases present with a 
spectrum of clinical signs and are classified based on 
clinical presentation, bacillary burden and immunolog-
ical and histological factors (Ridley & Jopling 1966). 
Cases that fall at one end of this spectrum, referred to 
as the tuberculoid pole, present with few lesions and 
low bacillary burdens; patients at this pole develop a T-
helper (Th)1 (cell-mediated) immune response against 
M. leprae. In contrast, patients at the lepromatous pole 
have a higher number of lesions and bacilli and develop 
a Th2 (humoral) immune response against M. leprae. 
The leprosy spectrum also contains intermediate forms 
of the disease referred to as borderline lepromatous 
(BL) or borderline tuberculoid leprosy. In addition, 
World Health Organization guidelines allow for the 
classification of leprosy cases as paucibacillary (PB) or 
multibacillary (MB) based on the number of lesions or 
the bacillary burden. 
Anaemia is a common finding in patients present-
ing with MB leprosy (Sher et al. 1981, Lapinsky et al. 
1992, Jain et al. 1995, Rea 2001). However, the exact 
mechanism underlying the reduction in serum iron and 
the effect of reduced iron levels on leprosy are not well 
understood. In this study, we investigated changes in pa-
rameters related to iron homeostasis in MB and consid-
ered for the first time the role of hepcidin in the progres-
sion of leprosy. 
SUBJECTS, MATERIALS AND METHODS
Subjects - A total of 38 leprosy patients (LP) were 
selected from an outpatient unit at the Lauro de Souza 
Lima Institute (ILSL), São Paulo, Brazil, a tertiary lep-
rosy reference hospital. All patients underwent clinical 
and histological evaluation and leprosy cases were clas-
sified based on the clinical criteria described by Rid-
ley and Jopling (1966). The bacilloscopic index of the 
biopsies was calculated as suggested by Ridley (1987). 
Twenty-five healthy control (HC) subjects were enrolled 
in this study. These control subjects were employees of 
the ILSL and their relatives.
For the measurement of iron metabolism parameters 
and cytokines in the blood and hepcidin levels in the 
urine, we enrolled 16 patients [7 BL and 9 lepromatous 
lepromatous (LL)] presenting with MB leprosy undergo-
ing multidrug therapy and 16 healthy gender and age-
matched control subjects. The LP were enrolled between 
the sixth and 12th month of treatment.
To assess hepcidin mRNA levels in the leprosy skin 
lesions, 13 MB patients [2 borderline-borderline (BB), 
6 BL and 5 LL] were enrolled immediately after being 
diagnosed with leprosy and six skin biopsies without 
histological abnormalities were used as controls. 
For immunofluorescence studies, nine skin lesion bi-
opsies from non-treated LP representative of each leprosy 
pole (i.e., tuberculoid-tuberculoid and LL) were obtained 
from the ILSL Pathology Service; three skin biopsies with 
non-inflammatory alterations were included as controls. 
This study was approved by the Ethical Committee of 
Human Experimentation at ILSL in accordance with the 
Helsinki Declaration of 1975. Written informed consent 
was obtained from all individuals included in the study.
Iron metabolism parameters and cytokine evaluations 
- Erythrograms were performed using an automated hae-
matologic analyser (AVL Roche, Indianapolis, IN, USA). 
Serum iron levels and total iron binding capacities (TIBC) 
were determined by a colourimetric ferrozine-based as-
say (Labtest, Belo Horizonte, MG, Brazil). The transfer-
rin saturation index (TSI) was calculated according to a 
standard method, as described by the assay manufacturer. 
The serum ferritin levels were measured by chemilumi-
nescence (Immulite; DPC, Los Angeles, CA, USA). 
The reticulocyte counts were performed after bril-
liant cresyl blue staining.
The serum levels of cytokines and soluble transfer-
rin receptor (sTfR) were measured using commercial 
ELISA assays for IL-1β, IL-6 and sTfR (R&D Systems, 
Minneapolis, MN, USA) and for tumour necrosis fac-
tor (TNF) (BD Biosciences, San Diego, CA, USA). The 
sTfR values were converted from nmol/L to mg/L to al-
low the calculation of the sTfR/log ferritin index.
Urinary hepcidin - The levels of urinary hepcidin 
were measured as described previously (Nemeth et al. 
2004) at University of California (Los Angeles, CA, 
USA) by Dr Seth Rivera. In brief, cationic peptides were 
purified using a CM Macro-prep (Bio-Rad, Hercules, 
CA, USA). After purification, urinary extracts contain-
ing 0.1-0.5 mg of creatinine and a range of concentra-
tions of a hepcidin standard were dotted on Immobi-
lon-P membranes (Millipore Corp, Bedford, MA, USA). 
Hepcidin was then bound with a polyclonal rabbit anti-
human hepcidin antibody produced by Dr Seth Rivera 
(University of California, Los Angeles) and detected by 
chemiluminescence using an Horseradish peroxidase-
conjugated goat anti-rabbit antibody.
RNA extraction and quantitative polymerase chain re-
action (qPCR) - The 5-mm punch biopsies were immersed 
in an RNA stabilisation solution (RNAlater; Ambion, 
Austin, TX, USA) and stored at -80ºC until processing. To 
collect the RNA samples, the biopsies were homogenised 
and the RNA was then isolated using a phenol-guanidine-
thiocyanate reagent (TRI Reagent; Ambion, Austin, TX, 
USA), chloroform and isopropanol. The total RNA (2 μg) 
was reverse transcribed to cDNA using 200 U of Super-
script II and 0.5 μg of oligo-dT according to the manufac-
turer’s instructions (Invitrogen, Carlsbad, CA, USA).
qPCR was performed with 1 µL of cDNA in a 20-µL 
reaction volume using iQ SYBR Green Supermix (Bio-
Rad). The reactions were performed in triplicate in an iQ5 
thermal cycler with a fluorescent imager (Bio-Rad). Hep-
cidin expression was evaluated by relative quantification 
and normalised to GAPDH expression as described by 
Pfaffl (2001). The following primer sequences were used: 
hepcidin forward, CCTGACCAGTGGCTCTGTTT, hep-
cidin reverse, CACATCCCACACTTTGATCG, GAPDH 
forward, TGGTATCGTGGAAGGACTC and GAPDH 
reverse, AGTAGAGGCAGGGATGATG.
Immunofluorescence - Fragments of tissue samples 
were fixed with 10% (w/v) neutral-buffered formalin, de-
hydrated and stored in paraffin until analysis. Five-micron 
tissue sections were applied to poly-L-lysine-coated mi-
croscope slides and stored at room temperature before im-
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munofluorescence analysis. Before labelling, the sections 
were deparaffinised in xylene and rehydrated in a graded 
series of ethanol baths (100%, 95%, 70% and 50%). Anti-
genic retrieval was subsequently performed with sodium 
citrate buffer. The slides were blocked with Protein Block 
Serum-Free Ready-To-Use buffer (Dako, Carpinteria, 
CA, USA). After being washed, the slides were incubated 
with the unconjugated primary anti-hepcidin (Abcam, 
Cambridge, UK) and anti-ferroportin antibodies (Alpha 
Diagnostics, San Antonio, TX, USA), washed again and 
incubated with the appropriate fluorochrome-conjugated 
(Fluorescein or Texas Red; Vector Laboratories Inc Bur-
lingame, CA, USA) secondary antibodies as well as 4′,6′-
diamidino-2-phenylindole. Secondary antibodies alone 
were used as negative controls. After being washed, the 
slides were mounted using 90% glycerol/phosphate buff-
ered saline and analysed using a confocal microscope. 
The images were acquired using Confocal Laser Scan-
ning Microscopy Leica TCS SPE and Leica Application 
Suite-Advanced Fluorescence software. Adobe Photoshop 
(version 4.0) was used for image processing. For quantita-
tive analysis of hepcidin and ferroportin expression, three 
microscopic fields were imaged and the number of posi-
tive cells was counted in each field.
Statistical analyses - To compare the serum variables in 
the patients and controls, the nonparametric Mann-Whit-
ney U-test was used. To compare the tuberculoid and lep-
romatous lesions and normal skin by immunofluorescence, 
the Kruskal-Wallis test was performed followed by Dunn’s 
multiple comparison test. The correlation between the 
hepcidin expression level and the bacilloscopic index was 
calculated using a nonparametric Spearman’s correlation 
test. The significance level was set at p < 0.05. All analy-
ses were performed with GraphPad Instat version 3.00 for 
Windows (GraphPad Software, San Diego, CA, USA).
RESULTS
Iron metabolism parameters and cytokine evaluation 
- We first measured the haematological parameters of the 
MB patients and HC subjects (Fig. 1). We found signifi-
cant decreases in haemoglobin (Hb), haematocrit (Ht), red 
blood cell count (RBC) and mean corpuscular volume 
(MCV) in the MB patients, as well as a tendency toward 
reduced red cell distribution width (RDW) values. How-
ever, only one patient presented critical values indicative 
of anaemia. The reticulocyte count was not significantly 
different between the LP and control subjects (Fig. 1). 
Iron parameters were next evaluated in the sera of 
LP and controls (Fig. 1). The TIBC values were lower 
in LP than in healthy individuals (p = 0.017). Moreover, 
we observed a marginally significant decrease in serum 
iron levels in LP (p = 0.054). The TSI values were simi-
lar between the two groups, whereas the serum ferri-
tin levels were slightly higher in the LP. The sTfR and 
sTfR/log ferritin index values were significantly higher 
in LP than in healthy individuals (p = 0.0002 and p = 
0.0054, respectively).
Fig. 1: measurements of haemoglobin (Hb), haematocrit (Ht), red blood cells (RBC), red cell distribution width (RDW), mean corpuscular 
volume (MCV), reticulocytes, serum iron, total iron binding capacity (TIBC), transferring saturation index (TSI), serum ferritin, soluble trans-
ferrin receptor (sTfR) and sTfR/log ferritin index in multibacillary leprosy patients (LP) and healthy controls (HC). Hb, Ht, RBC, MCV and 
TIBC showed significant decrease in LPs while serum ferritin, sTfR and sTfR/log ferritin index were increased. RDW and serum iron presented 
reduction with marginal significance. Bars represent medians. Nonparametric Mann-Whitney U-test was used to compare HCs and LPs.
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The serum levels of the pro-inflammatory cyto- 
kines IL-1β, IL-6 and TNF were compared in the LP and 
control subjects (Fig. 2). IL-1β levels were significantly 
higher in the LP than in the HC subjects (p = 0.013); 
however, the levels of IL-6 and TNF were similar be-
tween the groups. 
Hepcidin measurements - To better understand the 
role of hepcidin at sites of infection, the hepcidin lev-
els were evaluated in the urine and skin biopsies. Uri-
nary hepcidin levels were significantly higher in the LP 
than in the controls (p = 0.03) (Fig. 3A). In addition, the 
hepcidin expression levels in the biopsies of MB lesions 
were higher than those in the skin biopsies of healthy 
individuals (p = 0.0022) (Fig. 3B).  
Correlation analysis revealed that hepcidin levels are 
positively correlated with IL-1β levels in the serum of LP 
(r = 0.563, p = 0.04) (Fig. 3C). Moreover, qPCR analysis 
showed a positive correlation between hepcidin expres-
sion and the bacilloscopic index in a group of 13 MB and 
four PB biopsies (r = 0.482, p = 0.025) (Fig. 3D).
Immunofluorescence - We next evaluated the expres-
sion of hepcidin and ferroportin by immunofluorescence 
(Fig. 4). Ferroportin was expressed in intracellular and 
transmembrane compartments, whereas hepcidin was 
expressed more diffusely (Fig. 4). These molecules were 
not detected in the control samples. These results demon-
strated that the expression levels of hepcidin were signif-
icantly higher in polar LP than in the control subjects (p 
< 0.001) (Fig. 5). Immunostaining of the lesions revealed 
the absence of colocalisation of the studied molecules in 
all samples. Hepcidin was more highly expressed in lep-
romatous lesions than in tuberculoid lesions. However, 
higher levels of hepcidin than ferroportin were expressed 
in both lepromatous lesions and tuberculoid lesions. We 
observed significantly weaker ferroportin expression in 
the control group relative to the tuberculoid group (p < 
0.05). The lepromatous samples also expressed this pro-
tein, but at a lower level than tuberculoid samples. 
DISCUSSION
The manipulation of iron homeostasis by pathogens 
can influence the course of infectious diseases and most 
bacterial species possess iron acquisition mechanisms as 
virulence factors (Schaible & Kaufmann 2004). 
Lapinsky et al. (1992) reported the occurrence of 
anaemia in MB patients and classified this anaemia as 
AI on the basis of decreased serum iron levels and mild 
increases in serum ferritin concentrations.
In the present study, we have evaluated several pa-
rameters to better understand iron metabolism in LP. 
In particular, we have focused on the role of hepcidin 
in this process. Although only one leprosy patient ex-
hibited haematological parameters consistent with anae-
Fig. 2: measurements of interleukin (IL)-1β, IL-6 and tumour necrosis factor (TNF) in multibacillary leprosy patients (LP) and healthy controls 
(HC). IL-1β was increased in LP. Bars represent medians. Nonparametric Mann-Whitney U-test was used to compare HC and LP.
Fig. 3: evaluation of hepcidin in urine and skin samples from multibacillary leprosy patients (LP) and healthy controls (HC) and correlation of 
hepcidin with interleukin (IL)-1β and hepcidin with baciloscopic index in biopsies in LP. There is a significant increase in urinary hepcidin in 
the LP group. In the same way, relative expression of hepcidin mRNA is higher in biopsies from lepromatous leprosy lesions compared with 
normal skin. Hepcidin levels both in urine and biopsies were analyzed by nonparametric Mann-Whitney U-test and bars represent medians. 
There is a moderate correlation between urinary hepcidin and serum IL-1β in LP as well as a correlation between the hepcidin expression and 
the baciloscopic index in biopsies stained by Faraco-Fite. Nonparametric Mann-Whitney U-test was used to compare healthy controls and lep-
rosy patients. Correlations were analyzed by nonparametric Spearman correlation test. 
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mia, Hb, Ht, RBC, MCV and TIBC values were signifi-
cantly reduced in LP. Moreover, marginally significant 
decreases in RDW values and serum iron levels were 
observed in MB patients relative to HC subjects. These 
findings suggest a disturbance in iron metabolism dur-
ing the course of the disease. In addition, we found that 
LP presented increased levels of ferritin, sTfR and sTfR/
log ferritin index values. These features suggest that the 
LP presented a mixed anaemia including iron deficiency 
anaemia (IDA) and AI. Although haemolytic anaemia is 
a common finding after treatment with dapsone, part of 
the multidrug therapy for leprosy, we found no evidence 
of this condition when considering the direct and total 
bilirubin concentrations (data not shown).
The serum levels of ferritin were largely used to 
describe AI, since they are increased in this condition, 
while in IDA they are diminished. However, more re-
cent studies have suggested that sTfR and especially the 
sTfR/log ferritin index are better parameters to distin-
guish AI from IDA (Punnonen et al. 1997), as the lev-
els of sTfR are proportional to membrane expression of 
TfR, which increases in conditions of intracellular iron 
restriction. Thus, the levels of sTfR are normal in AI and 
elevated in IDA and combined anaemia; in contrast, the 
sTfR/log ferritin index values are normal in AI, strongly 
increased in IDA and moderately augmented in com-
bined anaemia (Punnonen et al. 1997). Taken together, 
our results point to a complex scenario regarding iron 
metabolism in MB patients in which both AI and IDA 
are present, as we observed increased levels of serum 
ferritin characteristic of AI in parallel with high levels 
of sTfR that reflect iron deficiency. The sTfR/log ferritin 
index values were mildly increased in the LP relative to 
the HC subjects, providing evidence for combined anae-
mia during the course of MB. In this context, hepcidin 
certainly acts as an important mediator connecting im-
mune response and iron metabolism in leprosy.
Through its role in regulating iron distribution, hep-
cidin is associated with inflammatory and infectious dis-
eases (Armitage et al. 2011, Oustamanolakis et al. 2011). 
In mice, the ablation of the hepcidin gene results in severe 
iron overload, whereas hepcidin overexpression induces 
perinatal death due to iron deficiency (Nicolas et al. 2001, 
2002). In our study, the hepcidin levels were higher in the 
urine and lesions of LP than in the urine and skin biopsies 
of HC subjects. Moreover, in skin biopsies, the hepcidin 
levels were also directly proportional to the bacilloscopic 
index. The induction of hepcidin by the pro-inflamma-
tory cytokines IL-6, IL-1 and TNF is thought to result 
in the retention of iron inside the host cells, limiting its 
availability for pathogens. Pro-inflammatory cytokines 
are also correlated with AI in non-infectious conditions, 
Fig. 4: expression of hepcidin and ferroportin in leprosy lesions. Biopsy samples were incubated with the appropriated fluorochrome-conjugated 
secondary antibodies (Texas Red or Fluorescein) as well as 4’,6’-diamidino-2-phenylindole (DAPI) (blue) and analyzed by confocal microscopy. 
The Fig. shows the expression of hepcidin (green) and ferroportin (in red) in control, polar tuberculoid (TT) and polar lepromatous (LL) samples 
(original magnification: 63X). 
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such as that observed in the elderly (Vanasse & Berlin-
er 2010). Our data showed increased IL-1β levels in the 
serum of LP and IL-1β levels were positively correlated 
with urinary hepcidin levels. In this context, the IL-1 β 
production in the course of leprosy seems to favour the 
synthesis of hepcidin that alters iron metabolism causing 
a degree of AI. To our knowledge, this is the first study 
regarding the role of hepcidin in leprosy.
In addition to its role in promoting intracellular iron 
retention to restrict the growth of extracellular pathogens, 
hepcidin also directly acts as an antimicrobial peptide. 
Hepcidin partially inhibits M. tuberculosis growth and 
promotes structural damage to the bacillus (Sow et al. 
2007). Despite its microbicidal role, the administration 
of exogenous hepcidin has been shown to enhance the 
growth of Chlamydia spp and Legionella pneumophila in 
macrophages; thus, it is possible that iron sequestration 
inside of the cells favours pathogen survival (Paradkar et 
al. 2008). In our study, hepcidin was present primarily in 
MB lesions, which contain a great number of bacilli. In 
this context, hepcidin-mediated iron sequestration could 
facilitate M. leprae growth. However, in leprosy lesions, 
most of the bacilli have a granular appearance sugges-
tive of bacillary death. Thus, a possible role for hepcidin 
in bacterial killing cannot be ruled out.
The mechanism by which hepcidin promotes in-
tracellular iron sequestration is based on the destruc-
tion of ferroportin (Theurl et al. 2008). Ferroportin is 
an iron transporter that functions as a transmembrane 
conduit for the transfer of cellular iron to the plasma; 
its abolishment restricts dietary iron absorption via en-
terocytes and iron release by macrophages. Ferroportin 
mRNA levels can be elevated by erythrophagocytosis 
or decreased by inflammation at the individual mac-
rophage level, whereas hepcidin is induced in response 
to increased iron reserves (Roy 2010). In MB biopsies, 
we observed many cells rich in hepcidin and fewer cells 
expressing ferroportin. In contrast, PB lesions exhibited 
fewer hepcidin-positive cells and more abundant ferro-
portin expression. These observations are in agreement 
with the model proposed for the control of iron seques-
tration by hepcidin and this model can help explain the 
optimal microenvironment provided by macrophages for 
M. leprae growth in susceptible individuals. Momotani 
et al. (1992) demonstrated that leprosy lesions express 
ferritin and lactoferrin, but little or no transferrin, sug-
gesting that the granuloma is a suitable environment for 
iron intake by M. leprae. Thus, excess iron can be as-
sociated with a poor prognosis in leprosy, as observed in 
tuberculosis. Therefore, iron supplementation should be 
administered cautiously (Boelaert et al. 2007).
Several experimental animal models classically dem-
onstrated the role of SLC11A1 (formerly natural resis-
tance-associated macrophage protein 1), a divalent metal 
transporter, in mice resistance to intracellular pathogens 
such as Mycobacterium, Salmonella and Leishmania 
(Vidal et al. 1995, Canonne-Hergaux et al. 1999). In hu-
mans, SLC11A1 is located at the phagosomal membrane 
and influences the iron content and pathogen survival 
in macrophages. Genetic associations between this gene 
and leprosy provide more evidence of the importance of 
iron transport proteins to its pathogenesis (Abel et al. 
1998, Meisner et al. 2001). In the present study, the focus 
on different iron transporters complements and extends 
the results previously described. This study constitutes 
an extensive investigation exploring the interplay be-
tween multiple iron transporters and intracellular mi-
croorganisms inside the macrophage. 
Taken together, our results demonstrate for the first 
time increased levels of hepcidin in the urine and lesions 
of MB patients presenting a combination of AI and IDA. 
The elevated hepcidin levels in LP could favour iron re-
tention inside macrophages and thereby support M. le-
prae growth. Further studies are necessary to elucidate 
the exact influence of hepcidin on M. leprae biology and 
leprosy pathophysiology.
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Fig. 5: quantitative analysis of the expression of hepcidin and ferro-
portin in leprosy samples. Results are the number of positive cells for 
hepcidin (A) and ferroportin (B) visualized by confocal microscopy 
in control, polar tuberculoid (TT) and polar lepromatous (LL) sam-
ples. The results are expressed as means ± standard deviation for nine 
TT and nine LL leprosy biopsies and three normal skin biopsies. Data 
were analyzed by Kruskal-Wallis test followed by Dunn’s Multiple 
Comparison Test. *: p < 0.05; **: p < 0.01; ***: p < 0.001 compared 
with control samples. 
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